SuperworthCytosorbents shares outstanding CTSO
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 3.1M
- On a year earlier
- −6.5%
- fewer shares
Cytosorbents had 3.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 6.5% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 3.1M | +15% |
| FY2024 | 2.7M | +18% |
| FY2023 | 2.3M | +7% |
| FY2022 | 2.2M | +0% |
| FY2021 | 2.2M | +1% |
| FY2020 | 2.2M | +33% |
| FY2019 | 1.6M | +2% |
| FY2018 | 1.6M | +10% |
| FY2017 | 1.4M | +13% |
| FY2016 | 1.3M | +1% |
| FY2015 | 1.3M | +13% |
| FY2014 | 1.1M | +126% |
| FY2013 | 493.4K | +16% |
| FY2012 | 425.3K | +19% |
| FY2011 | 358.7K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 3.1M | −6% | |
| Q1 FY26 | 3.1M | +3% | |
| Q4 FY25 | 3.1M | +15% | |
| Q3 FY25 | 3.1M | +15% | |
| Q2 FY25 | 3.4M | +24% | |
| Q1 FY25 | 3M | +12% | |
| Q4 FY24 | 2.7M | +18% | |
| Q3 FY24 | 2.7M | +23% | |
| Q2 FY24 | 2.7M | +23% | |
| Q1 FY24 | 2.7M | +25% | |
| Q4 FY23 | 2.3M | +7% | |
| Q3 FY23 | 2.2M | +2% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Cytosorbents
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.